Join the Sublocade group to help and get support from people like you.
Sublocade News (Page 2)
FDA Medwatch Alert: FDA Warns About Dental Problems with Buprenorphine Medicines Dissolved in the Mouth to Treat Opioid Use Disorder and Pain
What safety concern is FDA announcing? The U.S. Food and Drug Administration (FDA) is warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the...
FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing
ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....
FDA Approves Sublocade (buprenorphine) Once-Monthly Injection for Opioid Use Disorder
November 30, 2017 – The U.S. Food and Drug Administration today approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Opiate Dependence - Maintenance, Opiate Dependence